Gayatri BioOrganics Ltd
Gayatri BioOrganics Ltd (GAYATRIBI) last reported results for the quarter ended Jun 2026, with sales of ₹2.34 crore and net profit of ₹-0.1 crore. The stock last traded at ₹7.74, a market capitalisation of ₹61 crore. Over the past 52 weeks the stock has ranged between ₹6.25 and ₹20.2. Figures are as of 6 Oct 2026 and are not real time.
Gayatri BioOrganics Ltd share price and key metrics
- Current price
- ₹7.74
- Market cap
- ₹61 cr
- Book value
- ₹-4.7
- ROE
- %
- ROCE
- -152%
- Dividend yield
- 0.00%
- 52w high / low
- 20.2/6.25
Metrics as of 6 Oct 2026. Not real time.
Track Gayatri BioOrganics Ltd
Cruxal reads every Gayatri BioOrganics Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Gayatri BioOrganics Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- 7%
- 5 Years
- %
- 3 Years
- -3%
- TTM
- -23%
- 10 Years
- -6%
- 5 Years
- -5%
- 3 Years
- -8%
- 1 Year
- -36%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- %
Gayatri BioOrganics Ltd quarterly results
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.34 |
| Expenses | 0.11 | 0.08 | 0.1 | 0.18 | 0.12 | 0.13 | 0.32 | 2.33 |
| Operating profit | -0.11 | -0.08 | -0.1 | -0.18 | -0.12 | -0.13 | -0.32 | 0.01 |
| OPM % | — | — | — | — | — | — | — | 0.43% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0.07 | 0.08 | 0.07 | 0.08 | 0.09 | 0.09 | 0.1 | 0.11 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.18 | -0.16 | -0.17 | -0.26 | -0.21 | -0.22 | -0.42 | -0.1 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net profit | -0.18 | -0.16 | -0.17 | -0.26 | -0.21 | -0.22 | -0.42 | -0.1 |
| EPS (₹) | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 | -0.05 | -0.01 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Gayatri BioOrganics Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 79.32 | 173 | 155 | 0 | 0 | 0 | 1.67 | 0 | 0 | 0 | 2.34 |
| Operating profit | -49.21 | -23.86 | -3.61 | -0.61 | -0.5 | -0.5 | -0.77 | -0.53 | -0.45 | -0.75 | -0.56 |
| OPM % | -62.04% | -13.77% | -2.32% | — | — | — | -46.11% | — | — | — | -23.93% |
| Net profit | -82.65 | -19.14 | -15.51 | 84.47 | -0.5 | -0.5 | -1.01 | -0.68 | -0.73 | -1.11 | -0.95 |
| EPS (₹) | -10.49 | -2.43 | -1.97 | 10.72 | -0.06 | -0.06 | -0.13 | -0.09 | -0.09 | -0.14 | -0.12 |
TTM is the trailing twelve months to the most recent quarter.
Gayatri BioOrganics Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 |
| Reserves | -159.93 | -181.20 | -195.74 | -111.27 | -111.77 | -112.26 | -113.27 | -113.95 | -114.68 | -115.79 |
| Borrowings | 35.11 | 35.11 | 35.11 | 35.11 | 35.11 | 35.11 | 35.66 | 36.36 | 36.90 | 36.98 |
| Other liabilities | 150.81 | 212.77 | 226.93 | 0.46 | 0.47 | 0.60 | 0.44 | 0.37 | 0.66 | 1.74 |
| Total liabilities | 104.78 | 145.47 | 145.09 | 3.09 | 2.60 | 2.24 | 1.62 | 1.57 | 1.67 | 1.72 |
| Fixed assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other assets | 104.78 | 145.47 | 145.09 | 3.09 | 2.60 | 2.24 | 1.62 | 1.57 | 1.67 | 1.72 |
| Total assets | 104.78 | 145.47 | 145.09 | 3.09 | 2.60 | 2.24 | 1.62 | 1.57 | 1.67 | 1.72 |
As reported by the company. Total assets equal total liabilities by construction.
Gayatri BioOrganics Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -13.76 | -2.62 | -0.59 | 84.59 | -0.52 | -0.40 | -0.56 | -0.69 | -0.55 | -0.08 |
| Cash from investing | -0.75 | 2.62 | 0.82 | -83.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from financing | 15.53 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.56 | 0.70 | 0.54 | 0.74 |
| Net cash flow | 1.02 | 0.00 | 0.23 | 0.73 | -0.52 | -0.40 | -0.01 | 0.01 | -0.01 | 0.66 |
| Free cash flow | -16.06 | -2.62 | -0.59 | 84.59 | -0.52 | -0.40 | -0.56 | -0.69 | -0.55 | -0.08 |
| CFO / operating profit | 28% | 11% | 16% | -13,867% | 104% | 80% | 73% | 130% | 122% | 11% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Gayatri BioOrganics Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| ROCE % | -209.87% | — | — | -21.01% | -26.53% | -54.61% | -44.54% | -40.72% | -151.52% |
| Debtor days | 6.95 | 3.18 | 1.22 | — | — | 54.64 | — | — | — |
| Inventory days | 0.00 | 0.00 | 0.00 | — | — | 0.00 | — | — | — |
| Cash conversion cycle | 6.95 | 3.18 | 1.22 | — | — | 54.64 | — | — | — |
| Working capital days | -365.55 | -212.09 | -271.31 | — | — | -7,048.65 | — | — | — |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Gayatri BioOrganics Ltd shareholding pattern
Promoters held 21.59% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.01% and DIIs 0.23%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 40.62% | 43.78% | 21.59% | 21.59% | 21.59% | 21.59% | 21.59% | 21.59% |
| FIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| DIIs | 0.65% | 0.65% | 0.65% | 0.65% | 0.65% | 0.65% | 0.65% | 0.23% |
| Public | 58.71% | 55.56% | 77.76% | 77.75% | 77.77% | 77.76% | 77.75% | 78.17% |
| No. of shareholders | 33,801 | 33,734 | 33,441 | 32,749 | 32,123 | 31,471 | 30,796 | 30,442 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Gayatri BioOrganics Ltd corporate filings
- Gayatri BioOrganics Limited Announces Name Change to Ananth BioOrganics Limited Following 35th AGMAGM/EGMlow impact
Cruxal's analysis: Gayatri BioOrganics Limited has successfully concluded its 35th Annual General Meeting…
Read the full analysis - Gayatri BioOrganics Limited Announces Name Change to Ananth BioOrganics Limited and Leadership RestructuringAGM/EGMlow impact
Cruxal's analysis: Gayatri BioOrganics Limited has concluded its 35th Annual General Meeting, where…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
- Gayatri BioOrganics Limited Announces 35th AGM and Proposed Name Change to Ananth BioOrganics LimitedAGM/EGMmedium impact
Cruxal's analysis: Gayatri BioOrganics Limited has scheduled its 35th Annual General Meeting for September…
Read the full analysis - Gayatri BioOrganics Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Gayatri BioOrganics Ltd has filed its Annual Report for the financial year 2025-26. The…
Read the full analysis - Gayatri BioOrganics Limited announces resignation of Chairman and Non-Executive DirectorCompany Updatemedium impact
Cruxal's analysis: Gayatri BioOrganics Limited has received the resignation of Venkata Sandeep Kumar Reddy…
Read the full analysis - Gayatri BioOrganics reports first-time revenue of INR 2.34 crore, significantly narrows Q1 FY27 loss, and appoints new Chairman & Managing DirectorResulthigh impact
Cruxal's analysis: Gayatri BioOrganics Limited has announced its unaudited financial results for the quarter…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.